Chris Degnan - Net Worth and Insider Trading
Chris Degnan Net Worth
The estimated net worth of Chris Degnan is at least $27,640 dollars as of 2024-05-25. Chris Degnan is the CFO of Verrica Pharmaceuticals Inc and owns about 3,000 shares of Verrica Pharmaceuticals Inc (VRCA) stock worth over $25,680. Chris Degnan is also the CFO of Galera Therapeutics Inc and owns about 10,000 shares of Galera Therapeutics Inc (GRTX) stock worth over $1,960. Details can be seen in Chris Degnan's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Chris Degnan has not made any transactions after 2023-03-13 and currently still holds the listed stock(s).
Transaction Summary of Chris Degnan
Chris Degnan Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Chris Degnan owns 2 companies in total, including Galera Therapeutics Inc (GRTX) , and Verrica Pharmaceuticals Inc (VRCA) .
Click here to see the complete history of Chris Degnan’s form 4 insider trades.
Insider Ownership Summary of Chris Degnan
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| GRTX | Galera Therapeutics Inc | 2023-03-13 | Chief Financial Officer |
| VRCA | Verrica Pharmaceuticals Inc | 2018-06-19 | Chief Financial Officer |
Chris Degnan Latest Holdings Summary
Chris Degnan currently owns a total of 2 stocks. Among these stocks, Chris Degnan owns 3,000 shares of Verrica Pharmaceuticals Inc (VRCA) as of June 19, 2018, with a value of $25,680 and a weighting of 92.91%. Chris Degnan also owns 10,000 shares of Galera Therapeutics Inc (GRTX) as of March 13, 2023, with a value of $1,960 and a weighting of 7.09%.
Latest Holdings of Chris Degnan
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| VRCA | Verrica Pharmaceuticals Inc | 2018-06-19 | 3,000 | 8.56 | 25,680 |
| GRTX | Galera Therapeutics Inc | 2023-03-13 | 10,000 | 0.20 | 1,960 |
Holding Weightings of Chris Degnan
Chris Degnan Form 4 Trading Tracker
According to the SEC Form 4 filings, Chris Degnan has made a total of 0 transactions in Verrica Pharmaceuticals Inc (VRCA) over the past 5 years. The most-recent trade in Verrica Pharmaceuticals Inc is the acquisition of 3,000 shares on June 19, 2018, which cost Chris Degnan around $45,000.
According to the SEC Form 4 filings, Chris Degnan has made a total of 1 transactions in Galera Therapeutics Inc (GRTX) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Galera Therapeutics Inc is the acquisition of 10,000 shares on March 13, 2023, which cost Chris Degnan around $19,600.
Insider Trading History of Chris Degnan
- 1
Chris Degnan Trading Performance
GuruFocus tracks the stock performance after each of Chris Degnan's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Chris Degnan is 34.29%. GuruFocus also compares Chris Degnan's trading performance to market benchmark return within the same time period. The performance of stocks bought by Chris Degnan within 3 months outperforms 1 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Chris Degnan's insider trading performs compared to the benchmark.
Performance of Chris Degnan
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 20.37 | | | | | |
| Relative Return to S&P 500(%) | 15.84 | | | | | |
Chris Degnan Ownership Network
Chris Degnan Owned Company Details
What does Galera Therapeutics Inc do?
Who are the key executives at Galera Therapeutics Inc?
Chris Degnan is the Chief Financial Officer of Galera Therapeutics Inc. Other key executives at Galera Therapeutics Inc include Chief Commercial Officer Mark Bachleda , director & President and CEO Mel Sorensen , and Chief Medical Officer Eugene P. Kennedy .
Galera Therapeutics Inc (GRTX) Insider Trades Summary
Over the past 18 months, Chris Degnan made 1 insider transaction in Galera Therapeutics Inc (GRTX) with a net purchase of 10,000. Other recent insider transactions involving Galera Therapeutics Inc (GRTX) include a net purchase of 3,712,809 shares made by , a net purchase of 100,000 shares made by Mel Sorensen , and a net purchase of 11,000 shares made by Mark Bachleda .
In summary, during the past 3 months, insiders sold 0 shares of Galera Therapeutics Inc (GRTX) in total and bought 2,780,407 shares, with a net purchase of 2,780,407 shares. During the past 18 months, 0 shares of Galera Therapeutics Inc (GRTX) were sold and 3,833,809 shares were bought by its insiders, resulting in a net purchase of 3,833,809 shares.
Galera Therapeutics Inc (GRTX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Galera Therapeutics Inc Insider Transactions
Chris Degnan Mailing Address
Above is the net worth, insider trading, and ownership report for Chris Degnan. You might contact Chris Degnan via mailing address: C/o Verrica Pharmaceuticals Inc., 10 North High Street, Suite 200, West Chester Pa 19380.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
